Sugi Predict

Sugi Predict / Compounds / SCHEMBL3025867

SCHEMBL3025867

SCHEMBL3025867

O=C(O)C(O)C(O)C(O)C(O)C(O)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.64
▸ PDE4A P27815 1/20 0.60
▸ CYP2C9 P11712 2/20 0.52
▸ TP53 P04637 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.38
▸ LMNA P02545 2/20 0.36
▸ THRB P10828 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ OR51E2 Q9H255 1/20 0.35
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ ABCB11 O95342 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11345790 1.00 TSHR (0.64) TSHRPDE4ACYP2C9TP53ALDH1A1
SCHEMBL30562869 1.00 TSHR (0.64) TSHRPDE4ACYP2C9TP53ALDH1A1
SCHEMBL2216571 1.00 TSHR (0.64) TSHRPDE4ACYP2C9TP53ALDH1A1
SCHEMBL2963608 1.00 TSHR (0.64) TSHRPDE4ACYP2C9TP53ALDH1A1
Mucic Acid SCHEMBL3514596 0.96 TSHR (0.69) TSHRPDE4ACYP2C9TP53ALDH1A1
Mucic Acid SCHEMBL15895451 0.96 TSHR (0.69) TSHRPDE4ACYP2C9TP53ALDH1A1
Mucic Acid SCHEMBL17594183 0.96 TSHR (0.69) TSHRPDE4ACYP2C9TP53ALDH1A1
Mucic Acid SCHEMBL5497 0.96 TSHR (0.69) TSHRPDE4ACYP2C9TP53ALDH1A1
Mucic Acid SCHEMBL7224759 0.96 TSHR (0.69) TSHRPDE4ACYP2C9TP53ALDH1A1
Mucic Acid SCHEMBL77363 0.96 TSHR (0.69) TSHRPDE4ACYP2C9TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117903386-A Method for realizing liquid phase polymerization of high-concentration polyhydroxy aldehyde or (and) polyhydroxy ketone through liquid thereof under high-temperature condition 厦门碳控科技投资有限公司 2024-04-19 — — CN claimed
WO-2006084174-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ALKALINE PHARMACEUTICAL DRUGS YU RUEY J (US) 2006-08-10 — — WO claimed
US-20050196418-A1 Bioavailability and improved delivery of alkaline pharmaceutical drugs YU RUEY J (US) 2005-09-08 — — US claimed
US-20040214215-A1 Bioavailability and improved delivery of alkaline pharmaceutical drugs YU RUEY J (US) 2004-10-28 — — US claimed
CN-117903386-A Method for realizing liquid phase polymerization of high-concentration polyhydroxy aldehyde or (and) polyhydroxy ketone through liquid thereof under high-temperature condition 厦门碳控科技投资有限公司 2024-04-19 — — CN disclosed
CN-110996886-B Hair composition for wound treatment 联合利华知识产权控股有限公司 2023-03-28 — — CN disclosed
US-11547647-B2 Hair compositions for damage treatment CONOPCO, INC. (US) 2023-01-10 — — US disclosed
US-11369555-B2 Hair treatment compositions CONOPCO, INC. (US) 2022-06-28 — — US disclosed
CN-108778232-B Hair treatment composition 联合利华知识产权控股有限公司 2021-11-12 — — CN disclosed
EP-3664771-B1 HAIR COMPOSITIONS FOR DAMAGE TREATMENT UNILEVER PLC (GB) 2020-12-23 — — EP disclosed
EP-3188709-B1 TRANSPARENT COSMETIC AND PERSONAL CARE COMPOSITIONS UNILEVER PLC (GB) 2020-10-14 — — EP disclosed
US-20200268631-A1 HAIR COMPOSITIONS FOR DAMAGE TREATMENT CONOPCO, INC., D/B/A UNILEVER 2020-08-27 — — US disclosed
US-8466135-B2 Hair treatment compositions CONOPCO, INC. (US) 2013-06-18 — — US disclosed
US-20100202994-A1 HAIR TREATMENT COMPOSITIONS CONOPCO, INC. D/B/A UNILEVER 2010-08-12 — — US disclosed
US-20080113037-A1 Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs NEOSTRATA COMPANY, INC. 2008-05-15 — — US disclosed
US-20080032937-A1 Bioavailability and Improved Delivery of Alkaline Pharmaceutical Drugs YU RUEY J 2008-02-07 — — US disclosed
WO-2006084174-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ALKALINE PHARMACEUTICAL DRUGS YU RUEY J (US) 2006-08-10 — — WO disclosed
US-20050196418-A1 Bioavailability and improved delivery of alkaline pharmaceutical drugs YU RUEY J (US) 2005-09-08 — — US disclosed
US-20050171194-A1 Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions YU RUEY J (US) 2005-08-04 — — US disclosed
US-20040214215-A1 Bioavailability and improved delivery of alkaline pharmaceutical drugs YU RUEY J (US) 2004-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100202994-A1 HAIR TREATMENT COMPOSITIONS FUT6, FUT5, DPM1 TSHR 2362/4885PDE4A 1567/4885CYP2C9 3184/4885
US-11369555-B2 Hair treatment compositions KRT18, NACA, SHH TSHR 3442/4885PDE4A 3812/4885CYP2C9 4692/4885
US-11547647-B2 Hair compositions for damage treatment KRT18, CUTA, DSG1 TSHR 3539/4885PDE4A 3958/4885CYP2C9 4389/4885
US-20200268631-A1 HAIR COMPOSITIONS FOR DAMAGE TREATMENT KRT18, CUTA, DSG1 TSHR 3539/4885PDE4A 3958/4885CYP2C9 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.